Daclizumab high-yield process (HYP) is a humanized monoclonal antibody that binds to CD25 (alpha subunit of the interleukin-2 receptor) and modulates interleukin-2 signaling. Abnormalities in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback